SCHEMBL7986646

SCHEMBL7986646

CC(=O)N([C@H](CC(=O)O)c1cccc2ccccc12)N1C(=O)N[C@](C)(c2ccc(C(=N)N)cc2)C1=O

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 3/20 0.51
ITGA2B P08514 3/20 0.51
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
HTR1A P08908 2/20 0.34
DRD2 P14416 2/20 0.34
HTR7 P34969 2/20 0.34
CYP3A4 P08684 1/20 0.34
HDAC6 Q9UBN7 1/20 0.33
MAPT P10636 1/20 0.33
XBP1 P17861 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7986512 0.88 ITGB3 (0.56) ITGB3ITGA2BKMT2AMEN1CYP2C9
Hydrochloric Acid SCHEMBL8489120 0.88 ITGB3 (0.56) ITGB3ITGA2BKMT2AMEN1CYP2C9
Hydrochloric Acid SCHEMBL8488362 0.88 ITGB3 (0.56) ITGB3ITGA2BKMT2AMEN1CYP2C9
Hydrochloric Acid SCHEMBL7969557 0.88 ITGB3 (0.56) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL7446318 0.87 ITGB3 (0.38) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL8489046 0.85 ITGB3 (0.52) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL7981888 0.84 ITGB3 (0.50) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL7983582 0.84 ITGB3 (0.53) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL7985139 0.83 ITGB3 (0.49) ITGB3ITGA2BKMT2AMEN1CYP2C9
SCHEMBL7983505 0.83 ITGB3 (0.52) ITGB3ITGA2BKMT2AMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191282-B1 DERIVATIVES OF 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING IS USED AS ANTICARCINOGENIC AGENT AND ANTICOAGULANT HOECHST MARION ROUSSEL (DE) 2001-02-20 US disclosed
US-5981492-A ADMINISTERED TO THE PATIENT TO INHIBIT THROMBOCYTE AGGREGATION, THE METASTASIZATION OF CARCINOMA CELLS, THE BINDING OF OSTEOCLASTS TO THE BONE SURFACE, OR FOR THE TREATMENT OF THROMBOSES HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed